All Stories

  1. Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population
  2. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes
  3. Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort
  4. Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
  5. Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease
  6. Functional analysis of a novel de novo variant in PPP5C associated with microcephaly, seizures, and developmental delay
  7. Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling
  8. Plasma Protein Levels Analysis in Multiple Sclerosis Sardinian Families Identified C9 and CYP24A1 as Candidate Biomarkers
  9. Bilateral choanal stenosis in auriculocondylar syndrome caused by a PLCB4 variant
  10. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder
  11. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
  12. Homozygosity Haplotype and Whole-Exome Sequencing Analysis to Identify Potentially Functional Rare Variants Involved in Multiple Sclerosis among Sardinian Families
  13. Variable clinical severity in TANGO2 deficiency: Case series and literature review
  14. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations
  15. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11
  16. One is the loneliest number: genotypic matchmaking using the electronic health record
  17. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations
  18. Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden
  19. Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation
  20. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain
  21. Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
  22. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples
  23. “Doctors can read about it, they can know about it, but they've never lived with it”: How parents use social media throughout the diagnostic odyssey
  24. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases
  25. PPP3CA truncating variants clustered in the regulatory domain cause early‐onset refractory epilepsy
  26. TSPEAR variants are primarily associated with ectodermal dysplasia and tooth agenesis but not hearing loss: A novel cohort study
  27. Rare disease patient matchmaking: development and outcomes of an internet case-finding strategy in the Undiagnosed Diseases Network
  28. Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum
  29. Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey
  30. A novel de novo intronic variant in ITPR1 causes Gillespie syndrome
  31. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy
  32. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
  33. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease
  34. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science
  35. Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis
  36. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature
  37. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice
  38. Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans
  39. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder
  40. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
  41. Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage
  42. Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach
  43. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation
  44. Understanding Participation in Genetic Research Among Patients With Multiple Sclerosis: The Influences of Ethnicity, Gender, Education, and Age
  45. Race and ethnicity on MS presentation and disease course
  46. A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System
  47. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
  48. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
  49. Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein
  50. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein
  51. Fine-Mapping Array Design for Multi-Ethnic Studies of Multiple Sclerosis
  52. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy
  53. VarSight: prioritizing clinically reported variants with binary classification algorithms
  54. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects
  55. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
  56. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
  57. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States
  58. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
  59. Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
  60. The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach
  61. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification
  62. A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
  63. Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity
  64. Determinants of Poor Outcome after Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study
  65. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
  66. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
  67. Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis
  68. Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease
  69. Enrichment of rare protein truncating variants in amyotrophic lateral sclerosis patients
  70. Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report
  71. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
  72. Investigating multiple sclerosis genetic susceptibility on the founder population of east-central Sardinia via association and linkage analysis of immune-related loci
  73. MS in self-identified Hispanic/Latino individuals living in the US
  74. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba
  75. Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis
  76. Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort
  77. The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis
  78. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants
  79. NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk
  80. Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency
  81. European multiple sclerosis risk variants in the south Asian population
  82. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GMCSF
  83. Power estimation for non-standardized multisite studies
  84. GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis
  85. A catalog of HLA region SNPs with functional annotations, disease associations and correlations with HLA types
  86. Class II HLA interactions modulate genetic risk for multiple sclerosis
  87. Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype
  88. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia
  89. 942 Racial/Ethnic Groupings Influence Methylation Signatures of Colorectal Cancers
  90. An ImmunoChip study of multiple sclerosis risk in African Americans
  91. Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry
  92. Abstract B45: Microsatellite instability among disenfranchised minority colorectal cancer patients
  93. JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
  94. Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for Intracerebral Hemorrhage
  95. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
  96. Reconstructing the Population Genetic History of the Caribbean
  97. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
  98. Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
  99. A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
  100. Su1772 Do Hispanic Patients With a High Genetic Risk Load Develop IBD At a Younger Age?
  101. Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort Study
  102. Copy number variation in pediatric multiple sclerosis
  103. Evaluating Mitochondrial DNA Variation in Autism Spectrum Disorders
  104. Genome-Wide Association and Linkage Study in the Amish Detects a Novel Candidate Late-Onset Alzheimer Disease Gene
  105. Genetics in Diagnosing and Managing Inflammatory Bowel Disease
  106. Mitochondrial Haplogroup X is associated with successful aging in the Amish
  107. Genome-wide study for Alzheimer’s disease in the Amish
  108. A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6
  109. A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
  110. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility
  111. Genome-wide association study for dementia in the midwestern US Amish
  112. A Genome-wide Association Study of Autism Reveals a Common Novel Risk Locus at 5p14.1
  113. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
  114. The expanding genetic overlap between multiple sclerosis and type I diabetes
  115. P3-225: Whole-genome SNP linkage screen for dementia in the midwestern U.S. Amish
  116. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis
  117. SNPs in Multi-Species Conserved Sequences (MCS) as useful markers in association studies: a practical approach
  118. P1-287
  119. Lack of Association Between Autism andSLC25A12
  120. A genome-wide linkage analysis of dementia in the Amish
  121. Allelic Heterogeneity at the Serotonin Transporter Locus (SLC6A4) Confers Susceptibility to Autism and Rigid-Compulsive Behaviors
  122. A linkage disequilibrium map of the 1-Mb 15q12 GABAAreceptor subunit cluster and association to autism
  123. Dense linkage disequilibrium mapping in the 15q11–q13 maternal expression domain yields evidence for association in autism